Another biomarker, connecting low-grade inflammation and T2DM, is the soluble form of the haptoglobin-hemoglobin receptor CD163 (sCD163), with observational studies suggesting that individuals with obesity have increased concentrations of sCD163 [6] putting them at higher risk for T2DM [7]. The gene discussed is HP; the disease is type 2 diabetes mellitus.